<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="18257">Ornithine</z:chebi> decarboxylase (<z:mp ids='MP_0010716'>ODC</z:mp>) transgenic and alpha-difluoromethyl <z:chebi fb="0" ids="18257">ornithine</z:chebi> (DFMO)-treated rats were exposed to transient middle <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebral occlusion</z:e> (MCAO) to examine the role of intraischaemic <z:mp ids='MP_0010716'>ODC</z:mp>-activity on the evolution of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion damage </plain></SENT>
<SENT sid="1" pm="."><plain>Magnetic resonance imaging (MRI) data show that the damage develops slower in <z:mp ids='MP_0010716'>ODC</z:mp> transgenic than in DFMO-treated rats, which is not caused by a difference in perfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes are smaller in the former animals one day later </plain></SENT>
<SENT sid="3" pm="."><plain>These data support the idea of endogenous neuroprotective action of <z:mp ids='MP_0010716'>ODC</z:mp> </plain></SENT>
</text></document>